This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jim Cramer's 'Mad Money' Recap: Stop Panicking

Cramer was bearish on Questcor Pharmaceuticals (QCOR) and Ultra Petroleum (UPL).

Executive Decision: Stanley Crooke

For his "Executive Decision" segment, Cramer spoke to Dr. Stanley Crooke, chairman and CEO of Isis Pharmaceuticals (ISIS), a stock that's up 307% since Cramer last checked in back in October 2012.

Crooke said it's going to be an exciting year for Isis because his company has a ton of new drugs currently in trials, with lots of news coming on all fronts throughout the year.

Crooke sees substantial market opportunities for many of the drugs currently in development, which include everything from cholesterol to spinal muscular atrophy to several treatments for diabetes.

Must Read: Jim Cramer's 'Mad Money' Recap: An Irrational Market

Cramer agreed, saying that with so many drugs in development and so many milestones coming up soon, Isis remains one of his favorite drug discovery biotechs.

No Huddle Offense

In his "No Huddle Offense" segment, Cramer opined on the rally in the oil patch, a well-deserved move to the upside that is finally upon us.

Cramer said the independent oil and gas producers have come roaring back to life, thanks in part to a terrible winter that has sent crude prices higher. With production and reserves also on the rise, it's no wonder stocks like EOG Resources (EOG) are now hitting all-time highs.

Whether or now the controversial Keystone XL pipeline gets built, Cramer said he'd use any weakness in these stocks to be a buyer.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

-- Written by Scott Rutt in Washington, D.C.

To email Scott about this article, click here: Scott Rutt

Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC

At the time of publication, Cramer's Action Alerts PLUS had no positions in stocks mentioned.
3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ISIS $40.97 -0.05%
BIDU $194.30 0.00%
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs